Skip to main content
. Author manuscript; available in PMC: 2008 Sep 3.
Published in final edited form as: J Med Chem. 2007 May 10;50(11):2622–2639. doi: 10.1021/jm0613323

Figure 3.

Figure 3

Effects of 3-Cl-AHPC (5) and analogues 24, 31, 39, 43, 45, 48, 57, 60, and 63 on proliferation of trans-retinoic acid-refractory cancer cell lines after treatment for 72 h as described in the Experimental Section. (A) MDA-MB-231 breast cancer; (B) H292 lung cancer; and (C) DU-145 prostate cancer. Results shown are the averages of three replicates. Standard errors were below 10%